We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in the Cards for First Solar (FSLR) in Q3 Earnings?
Read MoreHide Full Article
First Solar, Inc. (FSLR - Free Report) is set to report third-quarter 2020 results on Oct 27, after market close.
In the last reported quarter, the company delivered an earnings surprise of 40.00%. It surpassed the Zacks Consensus Estimate in two of the trailing four quarters, the average surprise being 48.48%.
Let's take a closer look at the factors likely to have influenced the company’s performance.
Factors Under Consideration
First Solar has been witnessing strong demand for its Series 6 modules amid a challenging economic environment affected by the COVID-19 pandemic. As a result, the company had a strong Series 6 production rate and fleet-wide capacity utilization of more than 100% in July. Anticipating similar trends to have continued in the following two months of the third quarter, our hopes for First Solar’s revenues remain high.
Meanwhile, in August, the company’s Luz del Norte power plant in Chile secured approval from Coordinador Eléctrico Nacional, for delivering ancillary grid services on a commercial basis. This might have enabled the company to earn service revenues from this plant during the to-be-reported quarter.
Moreover, at the end of the July-September quarter, the company introduced its IQ 7A microinverters in the markets of Australia and Europe, which also reflects its capability to boost the quarterly top line.
In line with the aforementioned developments, the Zacks Consensus Estimate for third-quarter sales is pegged at $707.7 million, which suggests a 29.4% rise from the year-ago quarter’s reported figure.
First Solar had a strong beginning to the third quarter due to excess capacity utilization, which enables it to reduce cost-per-watt related to the Series 6 modules. Such lower cost-per-watt along with limited incremental severance costs expected during the second half of the year can be anticipated to have boosted the company’s overall gross margin in the third quarter. This is likely to have favorably impacted the bottom-line performance during the soon-to-be-reported quarter.
The Zacks Consensus Estimate for third-quarter earnings is pegged at 63 cents per share, indicating a surge of 117.2% year over year.
Earnings Whispers
Our proven model predicts an earnings beat for First Solar this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat.
Earnings ESP: The company’s Earnings ESP is +45.52%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Enphase Energy (ENPH - Free Report) carries a Zacks Rank #3 and is set to release third-quarter 2020 results on Oct 27.
SunPower Corporation (SPWR - Free Report) sports a Zacks Rank #1 and is set to release third-quarter 2020 results on Oct 28.
Sunnova Energy International (NOVA - Free Report) carries a Zacks Rank #3 and is set to release third-quarter 2020 results on Oct 29.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
What's in the Cards for First Solar (FSLR) in Q3 Earnings?
First Solar, Inc. (FSLR - Free Report) is set to report third-quarter 2020 results on Oct 27, after market close.
In the last reported quarter, the company delivered an earnings surprise of 40.00%. It surpassed the Zacks Consensus Estimate in two of the trailing four quarters, the average surprise being 48.48%.
Let's take a closer look at the factors likely to have influenced the company’s performance.
Factors Under Consideration
First Solar has been witnessing strong demand for its Series 6 modules amid a challenging economic environment affected by the COVID-19 pandemic. As a result, the company had a strong Series 6 production rate and fleet-wide capacity utilization of more than 100% in July. Anticipating similar trends to have continued in the following two months of the third quarter, our hopes for First Solar’s revenues remain high.
Meanwhile, in August, the company’s Luz del Norte power plant in Chile secured approval from Coordinador Eléctrico Nacional, for delivering ancillary grid services on a commercial basis. This might have enabled the company to earn service revenues from this plant during the to-be-reported quarter.
Moreover, at the end of the July-September quarter, the company introduced its IQ 7A microinverters in the markets of Australia and Europe, which also reflects its capability to boost the quarterly top line.
In line with the aforementioned developments, the Zacks Consensus Estimate for third-quarter sales is pegged at $707.7 million, which suggests a 29.4% rise from the year-ago quarter’s reported figure.
First Solar had a strong beginning to the third quarter due to excess capacity utilization, which enables it to reduce cost-per-watt related to the Series 6 modules. Such lower cost-per-watt along with limited incremental severance costs expected during the second half of the year can be anticipated to have boosted the company’s overall gross margin in the third quarter. This is likely to have favorably impacted the bottom-line performance during the soon-to-be-reported quarter.
The Zacks Consensus Estimate for third-quarter earnings is pegged at 63 cents per share, indicating a surge of 117.2% year over year.
Earnings Whispers
Our proven model predicts an earnings beat for First Solar this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat.
Earnings ESP: The company’s Earnings ESP is +45.52%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: First Solar currently carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
First Solar, Inc. Price and EPS Surprise
First Solar, Inc. price-eps-surprise | First Solar, Inc. Quote
Upcoming Solar Releases
Enphase Energy (ENPH - Free Report) carries a Zacks Rank #3 and is set to release third-quarter 2020 results on Oct 27.
SunPower Corporation (SPWR - Free Report) sports a Zacks Rank #1 and is set to release third-quarter 2020 results on Oct 28.
Sunnova Energy International (NOVA - Free Report) carries a Zacks Rank #3 and is set to release third-quarter 2020 results on Oct 29.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>